Mini Review
Volume 2 Issue 3 - 2018
Two Valuable Products for Healthy Vagina
GP Talwar* and Jagdish C Gupta
Talwar Research Foundation, New Delhi, India
*Corresponding Author: GP Talwar, Talwar Research Foundation, New Delhi, India.
Received: January 31, 2018; Published: August 18, 2018
Abstract
Described are 2 Products developed by us for improving the reproductive health of women. These are: (1) 3 strains of Lactobacilli (Pro-vag-Health) that possess arginine deiminase, the enzyme preventing the formation of foul odour derivatives, make and secrete high amounts of lactic acid besides being hydrophobic to enable colonization in the vagina, and (2) a Polyherbal formulation BASANT with inhibitory action on a wide spectrum of genital pathogens. The combined use of BASANT and Pro-vag-Health, has the highest efficacy for curing recurrent episodes of Vaginosis.
Introduction
I. Pro-vag-Health Probiotics
Vagina is a unique organ. While the pH of the human body is strictly regulated at 7.4, a healthy vagina has an acidic pH of around 4.5. This is materialized by co-existence on the vagina of a family of microorganisms called Lactobacilli. Lactobacilli make and secrete lactic acid which render the local pH acidic. There are many species of Lactobacilli and each species has strains that differ in their capacity of making lactic acid. Some make high amounts, others are low secretors, as was reported by us [1]. Figure 1 is a representation of this phenomenon.
Figure 1A: D-lactic acid production by 80 Lactobacillus strains from women with healthy vagina.
Figure 1B: D-lactic acid production by 124 Lactobacillus strains from women with Bacterial Vaginosis (BV) [1]
On the basis of their ability to make and secrete high amounts of lactic acid, hydrophobicity which enables their colonization, and possession of the enzyme arginine deiminase, which prevents the formation of foul odor derivatives, we selected 3 worthy strains of lactobacilli. These are (1)L. salivarius TRF # 30 (2) L. fermentum TRF # 36 and (3) L. gasseri TRF # 8. These have been patented and deposited in the International Depository. These have also been passed on to Industry, M/s Microbax Hyderabad, who have a set-up to culture probiotics on a mass-scale, lyophilize these along with stabilizer and pack in cellulose capsules that are easily insertable in the vagina. Vikas Rajurkar of M/s Microbax (India) Ltd can be contacted for these probiotic strains.
II. Polyherbal formulation BASANT
We developed a polyherbal formulation, which we have named as BASANT. It contains 95% pure curcumin (diferuloyl methane), purified extracts of Amla (Emblica officinalis), Aloe Vera (Aloe barbadensis) and Neem (Azadirachta indica) leaves along with pharmacopoeially approved excipients. BASANT has action on a wide spectrum of genital pathogens. It inhibits all strains of Neisseria gonorrhoeae tested, including those resistant to various antibiotics and drugs. It inhibits Candida glabrata, Candida albicans and Candida tropicalis including drugs-resistant strains isolated from women suffering from vulvo-vaginal candidiasis [2].
BASANT inhibits Chlamydia trachomatis in vitro, as well as when present in infected cells [3]. BASANT inhibits all strains of HIV (Human Immunodeficiency Virus) tested, which enter the blood lymphocytes employing either CXCR4 or CCR5 receptors as reported by Manoj Pastey at the University of Oregon, USA [4]. Of special interest is the ability of BASANT to inhibit Human Papilloma virus 16 (HPV-16), the virus which causes Carcinoma of Cervix, a major killer of women. What is further impressive is its ability to eliminate HPV-16 from infected cells at early CIN1 stage.
Table 1 shows data from a trial conducted in 11 women by Professor Sharma at the Jawaharlal Nehru Medical College Aligarh, Uttar Pradesh. 11 women whose cervical cells were infected with HPV-16, and whose Pap smear was abnormal, were asked to insert a capsule of BASANT in the vagina every night for 30 days, excluding the days of menstruation. Treatment with BASANT was effective in every woman. Not only the infected cervical cells became HPV-16 negative but also the Pap smear returned to normalcy [5].
Patient No. Age Parity HPV-16 Pre-treatment HPV-16 Post-treatment
1. 42 3+0 +VE NEGATIVE
2. 27 4+0 +VE NEGATIVE
3. 35 3+0 +VE NEGATIVE
4. 28 1+1 +VE NEGATIVE
5. 45 3+0 +VE NEGATIVE
6. 35 4+0 +VE NEGATIVE
7. 30 2+1 +VE NEGATIVE
8. 45 2+0 +VE NEGATIVE
9. 38 5+2 +VE NEGATIVE
10. 35 3+1 +VE NEGATIVE
11. 38 3+1 +VE NEGATIVE
Table 1: Pre and post treatment with BASANT of HPV-16 positive patients [5].
Synergistic action of BASANT and Pro-vag-Health in treatment of Vaginosis
Vaginosis is prevalent in 30-50% of women in urban and rural localities in India. Even in USA, its prevalence has been reported to be 29% [6]. A Phase II clinical trial conducted at the All India Institute of Medical Sciences, New Delhi and Sir Gangaram Hospital, New Delhi in 80 women suffering from recurring episodes of Vaginosis, showed that 7 night intake of either the 3 selected probiotics or BASANT cured 65-70% of such patients, but the combination of the 2 had remarkable efficacy of curing 95% of women suffering from Vaginosis manifested as abnormal vaginal discharge, presence of Clue cells loaded with aerobic, anaerobic micro-organisms and elevated ph. Figure 2 is a representation of a typical case before and after the treatment. Table 2 summarizes the results of this trial.
Group Name Women enrolled Women Improved P value Comparison with Placebo P value Comparison with BASANT + Probiotics
Probiotics 20 13 (65%) P<0.001 P = 0.04
BASANT 20 14 (70%) P<0.001 P = 0.09
BASANT + Probiotics
(NAUROZ)
20 19 (95%) P<0.001 -
Placebo 20 1 (5%) - P<0.001
Table 2: Summary of results of treatment with either Probiotics, BASANT or a combination of BASANT and Probiotics to cure Vaginosis and restore reproductive health [7].
Comparison with Fisher’s exact test
It was observed that while both Probiotics and BASANT restored healthy vagina, the combination of 2 cured Vaginosis in nearly every woman, 19 out of 20 women were cured [7]. This is the highest efficacy so far observed and reported in world literature. Metronidazole and other antibiotics currently employed attain only an efficacy of about 65%.
(a) Relief from Abnormal Vaginal Discharge
(b) Disappearance of Clue Cells
(c) Healing of fishy Odour
(d) pH of vagina restored to acidic range
Figure 2: An illustrative representation of a typical woman receiving treatment with NAUROZ, a combination of BASANT plus Pro-vag-Health [7].
References
  1. Garg KB., et al. “Metabolic properties of lactobacilli in women experiencing recurring episodes of bacterial Vaginosis with vaginal pH≥5”. European Journal of Clinical Microbiology & Infectious Diseases 29 (2010): 123-125.
  2. Talwar GP., et al. “A novel Polyherbal microbicide with inhibitory effect on bacterial, fungal and viral genital pathogens”. International Journal of Antimicrobial Agents 32.2 (2008): 180–185.
  3. Talwar GP., et al. “Potential of a novel polyherbal formulation BASANT for prevention of Chlamydia trachomatis infection”. International Journal of Antimicrobial Agents 32.1 (2008): 84–88.
  4. Talwar GP., et al. “Basant, a Polyherbal Topical Microbicide Candidate Inhibits Different Clades of Both CCR5 and CXCR4 Tropic, Lab-Adapted and Primary Isolates of Human Immunodeficiency Virus-1 in Vitro Infection”. Journal of Virology & Antiviral Research 3.4 (2014): 3.
  5. Talwar GP., et al. “BASANT, a Polyherbal Safe Microbicide Eliminates HPV-16 in Women with Early Cervical Intraepithelial Lesions”. Journal of Cancer Therapy 6 (2015): 1163-1166.
  6. Cudmore SL., et al. “Treatment of infections caused by Metronidazole-resistant Trichomonas vaginalis”. Clinical Microbiology Reviews 17.4 (2004): 783–793.
  7. Talwar GP., et al. “A Safe Wide Spectrum Polyherbal Microbicide and Three Meritorious Strains of Probiotics for Regressing Infections and Restoration of Vaginal Health (Regression of Vaginosis with BASANT and Probiotics)”. Journal of Women's Health Care 4 (2015): 256.
Citation: GP Talwar and Jagdish C Gupta. “Two Valuable Products for Healthy Vagina”. Gynaecology and Perinatology 2.3 (2018): 294-297.
Copyright: © 2018 GP Talwar and Jagdish C Gupta. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.